Global Multimodal Imaging Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
"Global Multimodal Imaging Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global multimodal imaging market report has been segmented on the basis of product, technology, application, end user, and region.
Global Multimodal Imaging Market: Overview
The multimodality imaging process is a combination of many imaging modalities. It offers a better solution in order to overcome the challenges or limitations of the independent techniques or process. The multimodality imaging includes magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT). The major role any multimodal imaging technique or approach is that it should offer the exact localization, extent, and metabolic activity of the target tissue. In recent times some multimodality instruments that have been developed such as micro-SPECT/μCT or micro-PET/μCT.
Global Multimodal Imaging Market: Dynamics
Increasing prevalence and incidences of chronic diseases such as cardiovascular disease, epilepsy, seizures, arthritis, obesity, etc. and an increasing number of geriatric population are the major factors expected to drive market growth in terms of revenue in the global market. In 2017, according to the United Nations, the world population aged 60 years and above touched too nearly 962 Mn and is expected to reach about 2,100 billion by 2050. In addition, the population of people aged 80 years and more is projected to increase at threefold between 2017 and 2050, rising from approximately 137 Mn to 425 Mn.
In addition, increasing spending on healthcare, developing medical facilities, increasing government initiatives, and proper favorable reimbursement schemes are some of the other factors expected to drive the growth revenue of the global multimodal imaging market over the forecast years. However, low awareness among the developing and under developing economies about multimodal imaging is a factor expected that could restrain the growth of the target market.
Global Multimodal Imaging Market: Segment Analysis
Among the technology segments, the PET/CT segment is expected to the largest revenue global market. This is primarily due to, high sensitivity of PET/CT technology and accuracy in the depiction of the tumour. In addition, many prominent players are engaged in the research and development activities of PET/CT systems and technology, and resulting in the higher installation of PET/CT systems across the globe. Among the application segments, clinical application is expected to account the highest revenue share, owing to the continuously growing prevalence of different chronic illness, and which is leading to increasing diagnostic examinations. Among the end user segment, hospitals are anticipated to account for the highest market share. This is primarily attributed to, an increasing the number of hospitals globally coupled with rising demand for diagnosis and treatment of diseases.
Global Multimodal Imaging Market: Region Analysis
The market in North America is projected to account for the foremost market share in the global market. This is primarily attributed to, a growing number of people sufferings from cardiac diseases According to the American Heart Association report in 2016, accounted for nearly 840,678 deaths in the US due to cardiovascular disease (CVD). The Asia Pacific is expected to register the fastest growing market for multimodal imaging owing to, growing government initiatives for the development of healthcare facilities in countries in the region.
Global Multimodal Imaging Market Segmentation
Segmentation by product:
- Multimodal imaging equipment
Segmentation by technology:
Segmentation by application:
- Clinical applications
Segmentation by end user:
- Diagnostic centers
- Academic & research institutes
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- GE Healthcare, Mediso Ltd.
- Siemens AG
- Koninklijke Philips N.V.
- MR Solutions Ltd.
- Bruker Corporation
- Canon Inc.
- Shanghai United Imaging Healthcare Co., Ltd.
- PerkinElmer, Inc.
- Northridge Tri-Modality Imaging, Inc.
- MILabs B.V.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!